Effect of vitamin D supplementation on pancreatic β-cell destruction and type 1 diabetes

Xiao-Bo Hu,Ting-Ting Duan,Jun Liu,Gao-Lu Zhu,Zhao-Hui Cao,Shao-Long Feng
DOI: https://doi.org/10.1097/cm9.0000000000001239
IF: 6.133
2020-11-04
Chinese Medical Journal
Abstract:Type 1 diabetes (T1D) is an organ-specific autoimmune disease with loss of pancreatic β-cells, characterized by reduced insulin levels and increased blood glucose.<sup><a class="ejp-citation-link js-ejp-citation-link">[1]</a></sup> The incidence of T1D is increasing by approximately 2% to 5% worldwide every year and becoming a global health problem.<sup><a class="ejp-citation-link js-ejp-citation-link">[2]</a></sup> Vitamin D (VD) deficiency was reported to be a risk factor in the development of T1D.<sup><a class="ejp-citation-link js-ejp-citation-link">[3]</a></sup> Recent studies showed that supplementation of VD alleviated disease symptoms in T1D patients. However, a few randomized controled trials (RCTs) demonstrated the clinical effect of VD treatment with inconsistent findings. This article aimed to evaluate the effect of VD supplementation in T1D, which is helpful to develop an adjuvant therapy for T1D.
medicine, general & internal
What problem does this paper attempt to address?